x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Answers from the Lab

Mayo Clinic Laboratories

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

health & fitness medicine

All Episodes

10:43

An Impactful Supreme Court Decision: Bill Morice,...

Answers from the Lab ·

2024/07/11

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss a case that was recently overturned by the Supreme Court of the United States that may have ramifications for the healthcare industry, including impacts on regulatory oversight.Their discussion includes:A summary of the Supreme Court ruling on June 28 to

en

10:09

The Metals Laboratory Tests Beethoven’s Hair: Paul...

Answers from the Lab ·

2024/07/04

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, and Sarah Erdahl, technical specialist coordinator in the Metals Laboratory. They discuss their unique opportunity to complete testing on locks of hair from the composer Ludwig von Beethoven.Specific topics of discussion include:How Mayo Clinic came to be involved in the project,

en

8:51

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

Answers from the Lab ·

2024/06/27

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the summertime activity of COVID-19 and the latest updates with avian influenza (H5N1).Their discussion includes:The recent rise in COVID cases and how the new FLiRT variants of the virus are affecting the immune system.Updates on avian influenza activity and

en

13:46

The Platform Transformation of Healthcare: Bill...

Answers from the Lab ·

2024/06/13

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the platform business model and how it’s being used in the healthcare industry to drive innovation and reimagine how care is provided.Their discussion includes:Key takeaways from the recent conference hosted by Mayo Clinic Platform.What constitutes a platform

en

16:55

Updates Streamline Autoimmune Neurology Testing:...

Answers from the Lab ·

2024/06/11

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.(00:32) Could you please give our listeners an overview of your role at Mayo Clinic? (01:22) What updates are happening in our laboratory to increase specificity when we receive a patient's serum and CSF for

en

15:11

Infectious Diseases on the Move: Bill Morice, M.D.,...

Answers from the Lab ·

2024/06/06

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss why measles remains a virus of concern, how avian flu continues to spread, and new developments in the federal regulation of laboratory-developed tests.Their discussion includes:How a person infected with measles recently traveled through a U.S. airport, and

en

14:27

Tests Aid Diagnosis of Cancer-Associated Neurological...

Answers from the Lab ·

2024/06/04

Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 assays facilitate care for central nervous system disorders triggered by cancer. Early diagnosis and treatment are important for managing disabling neurological symptoms and malignancy.(00:32) Could you tell us a bit about your background and your role at Mayo Clinic? (01:26) How do the tests that are coming live relate to the larger disease state of neurological disorders? (02:44) Can you share a

en

24:52

Get to Know DLMP’s Vice Chair of Research: Peter...

Answers from the Lab ·

2024/05/30

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Peter Lucas, M.D., Ph.D., vice chair of Research for the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic. Their discussion includes: Dr. Lucas’ extensive pathology and research background and his journey to Mayo Clinic. His goals for expanding DLMP’s research activities and advancing innovation in diagnostics.How laboratory

en

10:43

Avian Flu Outbreaks and New COVID-19 Variants:...

Answers from the Lab ·

2024/05/23

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist at Mayo Clinic. They discuss the widespread outbreaks of H5N1 bird flu and the new “FLiRT” variants of COVID-19.Specific topics of discussion include:The current situation of avian flu activity across the world and throughout the United States, including

en

14:19

Enhanced Solid Tumor NGS Panel Broadens...

Answers from the Lab ·

2024/05/21

Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S., explain how Mayo Clinic Laboratories' augmented MayoComplete Solid Tumor Panel better profiles tumor genetics. Defining tumor pathogenesis can guide targeted cancer therapy. (00:31) Can you tell us a little about yourself and your background — Beth? (01:24) Stephanie, what about you? (01:42) Dr. Jenkins, a little bit about yourself and your background, please? (02:25) Could you provide a brief overview of the new

en

24:17

New Panels Help Find Cause of Rapidly Progressive...

Answers from the Lab ·

2024/05/14

Rapidly progressive dementia covers many conditions, including Creutzfeldt-Jacob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' new evaluations help identify the cause of rapidly progressive dementia, to guide prognosis and treatment decisions.Show notesSpeaker 3: (00:32) Can you provide a little background about your role here at Mayo Clinic and experience with this disease state? Speaker 3: (01:21) Can you give us an understanding of rapidly progressive

en

12:13

Get to Know the DLMP Chair: Eric Hsi, M.D.

Answers from the Lab ·

2024/05/09

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Eric Hsi, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. Their discussion includes:Dr. Hsi’s experience in the field of pathology and what he is looking forward to working on as the new chair of the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic.Some common challenges facing laboratory

en

7:39

Oral fluid offers an alternative specimen for...

Answers from the Lab ·

2024/05/07

Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.(00:32) Can you tell us a little bit about yourself and your background? (01:46) Can you please provide an overview of laboratory testing for substance use disorders and specifically Mayo Clinic's new oral fluid controlled substance monitoring option? (03:47) Which patients should have this testing

en

18:20

FDA Issues Final Rule to Regulate LDTs: Bill Morice,...

Answers from the Lab ·

2024/05/02

In this special episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the final rule issued by the U.S. Food and Drug Administration (FDA) on April 29, 2024, to make explicit its plan to regulate laboratory-developed tests (LDT) as medical devices under the Federal Food, Drug, and Cosmetic Act.Their discussion

en

8:18

The Growing Crisis of Antimicrobial Resistance: Robin...

Answers from the Lab ·

2024/05/02

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Robin Patel, M.D.,director of the Infectious Diseases Research Laboratory and co-director of the Bacteriology Laboratory at Mayo Clinic. They discuss antimicrobial resistance and why it’s a major global health concern.Specific topics of discussion include:Background information on antimicrobial resistance and why it is a growing threat to global

en

14:52

Assay provides quick diagnosis of VEXAS syndrome:...

Answers from the Lab ·

2024/04/30

David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.(00:31) Could you please provide a little bit about yourself and your background? (01:30) Would you please share a brief overview of the UBA1Q assay? (02:13) Would you provide an overview of VEXAS syndrome? (05:30) When

en

11:14

Alzheimer’s Disease and Testing Innovations: Bill...

Answers from the Lab ·

2024/04/25

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss testing innovations for Alzheimer’s disease and cognitive impairments, and how laboratorians can responsibly help shape the future of healthcare.Their discussion includes:The latest news about the U.S. Food and Drug Administration’s (FDA) proposed rule around

en

5:51

Assay identifies patients eligible for new ovarian...

Answers from the Lab ·

2024/04/23

Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication. (00:32) Could you provide us with a little bit of information about yourself and your background? (01:18) Can you start with a brief overview of the assay? (02:13) Which patients should have this

en

11:08

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

Answers from the Lab ·

2024/04/18

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including Medical Laboratory Professionals Week, recent healthcare conferences, advocacy efforts, measles, and bird flu.Their discussion includes:Key takeaways from the Becker’s Healthcare Annual Meeting and the College of American Pathologists’

en

9:04

Assay monitors response to monoclonal antibody...

Answers from the Lab ·

2024/04/16

Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease.(00:32) Do you mind giving the audience more information about yourself and your background? (01:53) Could you please give a brief overview of this assay? (03:35) Which patients should have this testing and when should it be performed? (04:57) How

en

371 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown